Molecular Templates, Inc. (MTEM)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Jan 31, 2025, 4:00 PM EST
Molecular Templates Employees
Molecular Templates had 62 employees as of December 31, 2023. The number of employees decreased by 49 or -44.14% compared to the previous year.
Employees
62
Change (1Y)
-49
Growth (1Y)
-44.14%
Revenue / Employee
$410,806
Profits / Employee
-$252,032
Market Cap
1.98K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
CytoDyn | 9 |
SANUWAVE Health | 31 |
Molecular Templates News
- 6 weeks ago - Why Molecular Templates (MTEM) Stock Is Down 60% - Benzinga
- 6 weeks ago - Molecular Templates shares tumble on Nasdaq delisting - Seeking Alpha
- 6 weeks ago - Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules - GlobeNewsWire
- 2 months ago - Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements - GlobeNewsWire
- 6 months ago - Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 8 months ago - Molecular Templates, Inc. Provides Interim Update - GlobeNewsWire
- 9 months ago - Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 10 months ago - Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patie - GlobeNewsWire